FIELD: medicine, endocrinology.
SUBSTANCE: invention relates to a method for treatment of diabetes mellitus. For this aim in carrying out the conventional complex therapy granocyte is administrated to patient in the dose 66800000 IU per a day, not above, on 2-6 days of treatment. Method results to normalization of blood and urine glucose levels in reducing the daily dose of insulin or withdrawal of preparations with hypoglycemic effect.
EFFECT: improved method for treatment.
4 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS | 2003 |
|
RU2243784C2 |
| METHOD FOR TREATING MYOCARDIAL INFARCTION | 2003 |
|
RU2245162C2 |
| METHOD FOR TREATING PATIENTS WITH NON-INSULIN DEPENDENT DIABETES MELLITUS (TYPE II) | 2004 |
|
RU2282453C2 |
| ANTIDIABETIC AGENT WITH HYPOLIPIDEMIC ACTIVITY FOR TREATMENT AND PREVENTION OF INSULAR DIABETES II TYPE | 2007 |
|
RU2337698C1 |
| METHOD TO TREAT INSULIN-INDEPENDENT DIABETES MELLITUS (TYPE II) ACCOMPANIED WITH ADIPOSIS DOLOROSA | 1997 |
|
RU2112509C1 |
| BIOTRANSPLANT AND METHOD FOR TREATING THE CASES OF DIABETES MELLITUS OF TYPE I AND II | 2004 |
|
RU2265443C1 |
| PHARMACEUTICAL COMPOSITION POSSESSING ANTIDIABETIC, HYPOLIPIDEMIC, HYPOGLYCEMIC AND CHOLESTEROL LOWERING ACTION, WAY OF ITS RECEPTION AND WAYS OF TREATMENT OF SPECIFIED DISEASES | 2007 |
|
RU2361581C2 |
| SOLIDPHASE COMPOSITION OF NATURAL BIOACTIVE INGREDIENTS FOR CORRECTION OF METABOLIC DISTURBANCES IN DIABETES MELLITUS TYPE II | 2017 |
|
RU2661622C1 |
| MEDICATION AND METHOD OF COMPLEX THERAPY OF PATIENTS WITH DIABETES MELLITUS | 2012 |
|
RU2548731C2 |
| METHOD FOR CONTROLLING INSULIN SECRETION BY PANCREATIC Β-CELLS USING THERMOGENETICS | 2022 |
|
RU2815935C1 |
